Why an obscure Supreme Court case is a big deal for prescription drugs


Why an obscure Supreme Court case is a big deal for prescription drugs

“Consumers and the health system as a whole benefit from a more competitive prescription drug market,” Marilyn Tavenner, president and CEO of America’s Health Insurance Plans, said in a statement. “Protecting monopoly-like pricing schemes threaten[s] consumers’ access to more affordable prescription medications.”

Leave a comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.